123 related articles for article (PubMed ID: 389484)
21. Puerperal lactation inhibition with a novel 8 alpha-aminoergoline (CU 32-085).
Kvist Poulsen H; Rasmussen P; Riber Petersen M; Møller Pedersen S
Gynecol Obstet Invest; 1984; 17(3):139-44. PubMed ID: 6706248
[TBL] [Abstract][Full Text] [Related]
22. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
[TBL] [Abstract][Full Text] [Related]
23. Oral cabergoline. Single-dose inhibition of puerperal lactation.
Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
[TBL] [Abstract][Full Text] [Related]
24. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
[TBL] [Abstract][Full Text] [Related]
25. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of prolactin and lactation by methylergometrine hydrogenmaleate.
Peters F; Lummerich M; Breckwoldt M
Acta Endocrinol (Copenh); 1979 Jun; 91(2):213-6. PubMed ID: 463447
[TBL] [Abstract][Full Text] [Related]
27. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
Walker S
Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
[No Abstract] [Full Text] [Related]
28. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
Mueller GP; Simpkins J; Meites J; Moore KE
Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
[TBL] [Abstract][Full Text] [Related]
30. The effect of furosemide on serum prolactin levels in the postpartum period.
Kalk WJ; Cominos DC; van der Walt A; van Rooyen AJ
S Afr Med J; 1977 Sep; 52(12):485-6. PubMed ID: 905911
[TBL] [Abstract][Full Text] [Related]
31. Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat.
Reid JL; Lewis PJ; Myers MG
Neuropharmacology; 1975 Mar; 14(3):215-20. PubMed ID: 1134626
[No Abstract] [Full Text] [Related]
32. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
[No Abstract] [Full Text] [Related]
33. Controlled telethermographic study of the peripheral vasoactivity of oral piribedil.
Huys J; Brems H; de Schrijver A
Curr Med Res Opin; 1977; 4(9):654-9. PubMed ID: 338254
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of dopaminergic tone in postmenopausal women: effects of piribedil on anterior pituitary hormones.
De Marinis L; Mancini A; Calabrò F; Sciuto R; Fiumara C; Zuppi P; Saporosi A; Barini A; Menini E
Horm Metab Res; 1991 Jan; 23(1):30-4. PubMed ID: 1849868
[TBL] [Abstract][Full Text] [Related]
35. Domperidone: secretion in breast milk and effect on puerperal prolactin levels.
Hofmeyr GJ; Van Iddekinge B; Blott JA
Br J Obstet Gynaecol; 1985 Feb; 92(2):141-4. PubMed ID: 3882143
[TBL] [Abstract][Full Text] [Related]
36. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
Krulich L; McCann SM; Mayfield MA
Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
[TBL] [Abstract][Full Text] [Related]
37. Plasma prolactin and puerperal blood pressure.
Jenkins DM; Soltan MH
Br J Obstet Gynaecol; 1980 Jul; 87(7):597-9. PubMed ID: 7426514
[TBL] [Abstract][Full Text] [Related]
38. Effect of ergonovine maleate on puerperal prolactin.
Shane JM; Naftolin F
Am J Obstet Gynecol; 1974 Sep; 120(1):129-31. PubMed ID: 4602154
[No Abstract] [Full Text] [Related]
39. Lack of effect of chronic haloperidol administration on the prolactinlowering actions of peribedil.
Ravitz AJ; Moore KE
J Pharm Pharmacol; 1977 Jun; 29(6):384-6. PubMed ID: 18585
[No Abstract] [Full Text] [Related]
40. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
